The primary objective is to demonstrate, in a population of chronic neuromuscular disease the non-inferiority of a rehabilitation treatment integrated with robotic and/or technological devices compared to traditional rehabilitation treatment in the level of fatigue.
The main question it aims to answer is:
Are high-tech rehabilitation interventions, including robotic systems, virtual reality, and stabilometric platforms, not inferior to traditional rehabilitation methods in improving balance, motor function, fatigue levels, sarcopenia, cognitive engagement, and overall quality of life in patients with chronic neuromuscular diseases (NMDs)? Researchers will compare a robotic treatment group, that consists in an high-tech rehabilitation, with a control group, that will receive the traditional rehabilitative treatment.
Patients with a confirmed diagnosis of chronic neuromuscular diseases (e.g. ALS, CIDP, CMT)
Patient able to walk independently or with assistance
Patients capable of understanding and adhering to the study protocol.
Patients who have provided informed consent to participate in the study
Patients with unstable medical conditions (e.g. severe cardiovascular diseases, such as "New York Heart Association" - NYHA=4, respiratory distress not compensated by ventilation) that could interfere, in the clinician's judgment, with their ability to safely participate in the study or to perform the assessments related to the protocol.
Patients currently participating in other clinical trials that could interfere with this study.
Pregnant women.
Istituti Clinici Scientifici Maugeri SpA
Lead sponsor
Ospedale Policlinico San Martino
Collaborator
Azienda Ospedaliero-Universitaria di Modena
Collaborator
Fondazione Don Carlo Gnocchi Onlus
Collaborator